Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
India ranks second after China in the global diabetes epidemic, with 77 million people suffering from the condition in the ...
As though diabetes, obesity, or hypertension alone would be bad enough, all three conditions together are bad news and a ...
NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...
This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...
It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...
This is not only a sustainability consideration but also a patient safety issue as insulin that has been stored incorrectly may not have the expected effect on blood glucose. I have had type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback